LDC and Roche will jointly advance innovative drug discovery projects

LDC Enters new Industry Partnership for the Discovery of Novel Medicines

25-Jan-2016 - Germany

The Lead Discovery Center GmbH (LDC) and Roche will collaborate to identify and leverage innovative therapeutic opportunities that address diseases of unmet medical need across several disease areas.

Projects will be sourced from the LDC’s academic partners, as well as from Roche’s innovation network. The partners will work together to advance projects from as early as target level up to the identification of a preclinical candidate. Over an initial three year period, LDC will act as a translational incubator for Roche and carry out small molecule projects in close collaboration with the scientific inventors and their academic institutions.

Upon attainment of a predefined milestone, Roche has option rights to an exclusive license. The terms and conditions of collaboration and licensing will be agreed on a project-by-project basis to ensure a fair balance of investments and potential returns between the partners. Any revenue the LDC may receive from a potential future commercialization will be shared with the academic inventors and collaborating institutions. Roche’s contributions will include research funding and possibly in-kind support required for optimal project progress, such as access to compound libraries.

Other news from the department business & finance

These products might interest you

Pharmaceutical Substances

Pharmaceutical Substances by Thieme Verlag

Look up Industrial Syntheses of 2,600 APIs

Your tool for Syntheses, Patents and Applications – Pharmaceutical Substances

technical literature
KNAUER IJM NanoScaler

KNAUER IJM NanoScaler by KNAUER

Efficient formulation of lipid nanoparticles for RNA-based therapies

Optimise drug encapsulation from 1 ml to hundreds of millilitres with minimal drug input

formulation systems
Loading...

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance